focus -WSS

focus

author：hotspot 2025-09-30 08:00:48 - browse：632

Doctor holding a clipboard. -- health coverage from STAT — Adobe

The momentum around weight loss drugs is about to get even bigger in the wake of Novo Nordisk’s announcement that its semaglutide drug Wegovy cut the risk of cardiovascular disease by 20% in its large SELECT trial.

The full results of the study, funded by Novo, will be presented at the American Heart Association meeting in November. Doctors and researchers say they expect the findings to have a big impact on how clinicians approach the treatment of both obesity and cardiovascular disease, as well as increase the likelihood that prescriptions for obesity drugs will be covered by insurance.

But experts who spoke with STAT also cautioned that the long-term safety and efficacy of Wegovy and other weight loss drugs remain unknown. The SELECT study has yet to be peer-reviewed, and not enough information is yet available to make independent assessments of the results.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： PhRMA lawsuit over Medicare drug price negotiation tossed

explore

WSS

KalVista pill reduced swelling 'attacks' caused by genetic disease

BioAge raises $170M for combination therapy with Zepbound

Tornado touches down near Chicago's O'Hare airport amid extreme weather nationwide

Vaccine advisory panel ACIP left half staffed by HHS

Sickle cell gene therapy cures need to be accessible in Africa

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

leisure time

focus

focus

Medical leaders decry Supreme Court decision on affirmative action

Companies helping big Covid

Apple is now the first public company to be valued at $3 trillion

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

United colonoscopy coverage change 'may cost lives,' doctors say

Medicare threatens to cut off funding for HCA's Mission hospital

Jerome Adams on the need for new antivirals for Covid

PhRMA lawsuit over Medicare drug price negotiation tossed

Drug repurposing or repositioning? The language matters

Britney Spears to release memoir, 'The Woman In Me,' later this year

knowledge

Readout LOUD podcast: How biotech is using artificial intelligence

One Duchenne patient's bittersweet hope for new treatment

Medical mystery: When a cough is not just a cough

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

EU fines Illumina $475 million over Grail acquisition

KalVista pill reduced swelling 'attacks' caused by genetic disease

explore

knowledge

explore

entertainment